이연제약
102460KOSPI52.8 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Il Yeon Pharm is a specialized pharmaceutical company established in 1964, focusing on the manufacturing and sales of prescription drugs, original pharmaceuticals (e.g., CT contrast agent 'Optirey'), and bulk drugs. Its Chungju facility, certified for biopharmaceutical production and CMO services, supports new drug pipeline development through a production-platform-based R&D model. However, as of 2024, the company reported sales of 145.9 billion won, an operating loss of 30.3 billion won, and a net loss of 29.6 billion won, indicating the need for improved profitability.
Number of Employees
457people
Average Salary
76.4M KRW
Score Calculation Basis
Detailed Financial Score
Lower than industry avg (good)
Well below industry avg
Half of industry avg (excellent)
Avg ▼1.7% (2-year basis)
Avg ▼19193.7% (2-year basis)
Avg ROE -3.2% (declining, 3yr)
Detailed News Sentiment
- Positive이연제약 "트롬빈 글로벌 시장 진출…해외 파트너와 공급 협력 추진"
이연제약의 트롬빈 글로벌 공급망 확장 계획 발표로 인해 시장 경쟁력 강화 기대.
- Positive유용환 이연제약 대표 "충주공장 가치 빛 볼 것…글로벌 CMO 계약 자...
이연제약의 충주공장 투자가 글로벌 CMO 계약 체결로 인해 긍정적인 전략적 가치를 인정받고 있다.
Detailed Momentum
Near 52w low (6%, downtrend)
1m -0.9% (flat)
Volume decreasing
Detailed Disclosure
- Neutral반기보고서 (2026.06)2026-08-14
